NAFLD Indirectly Impairs Antigen Specific CD8⁺ T Cell Immunity against Liver Cancer in Mice

Scientists generated a doxycycline inducible MHC-I and II antigen expressing HCC cell line which allowed them to investigate tumor antigen specific T cell response in two non-alcoholic fatty liver disease (NAFLD) mouse models.